This inventor holds 6 USPTO granted patents. Top assignees: The University of Texas System, Wyeth Holdings Corporation, Other. Active years: 2001-2009.
Location History:
- Gasel, CH (2001 - 2009)
- Gaselstrasse, CH (2007 - 2009)
Company Filing History:
4 out of 5,627 
2 out of 113 
2 out of 834,350 Years Active: 2001-2009
Title: Christoph Aebi: Innovator in Molecular Biology
Introduction
Christoph Aebi is a notable inventor based in Gaselstrasse, Switzerland. He has made significant contributions to the field of molecular biology, particularly through his innovative research and patents. With a total of 6 patents, Aebi has established himself as a key figure in the scientific community.
Latest Patents
One of Aebi's latest patents involves the UspA2 nucleic acid of Moraxella catarrhalis. This invention discloses the existence of two novel proteins, UspA1 and UspA2, along with their respective genes, uspA1 and uspA2. Each protein contains a conserved region and an epitope recognized by the monoclonal antibody MAb 17C7. These proteins may aggregate to form a very high molecular weight form of the UspA antigen, exceeding 200 kDa. The patent also includes compositions and methods for both diagnostic and therapeutic applications related to these proteins.
Career Highlights
Throughout his career, Christoph Aebi has worked with prestigious organizations, including the University of Texas System and Wyeth Holdings Corporation. His work has significantly advanced the understanding of molecular interactions and their implications in health and disease.
Collaborations
Aebi has collaborated with notable colleagues, including Leslie D Cope and Michael J Fiske. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Christoph Aebi's contributions to molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and pave the way for future innovations.